Similar Items: In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
- Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein
- Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
- An investigation of the in vivo role of vaccinia virus complement control protein in head injury and Alzheimer's disease
- An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
- An investigation into the specific function of the vaccinia virus :13.8 kDa protein encoded by the N1L gene
- A study of host genetic determinants of human papillomavirus (HPV) infection, cervical cancer and herpes simplex virus type-2 (HSV-2) infection
Author: Kotwal, Girish J
- An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
- Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
- An investigation into the specific function of the vaccinia virus :13.8 kDa protein encoded by the N1L gene
- Cloning and expression of a functionally active truncated N-glycosylated KSHV complement regulatory protein and immunohistochemical studies with the anti-KCP peptide antibody
- In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
- An investigation of the in vivo role of vaccinia virus complement control protein in head injury and Alzheimer's disease